Remarks by Acting FDA Commissioner Stephen M. Ostroff, MD

FDLI ANNUAL CONFERENCE
MAY 4, 2017
WASHINGTON, DC

FDA: LOOKING BACK, LOOKING FORWARD

Introduction

Good morning. Thank you Amy [Comstock Rick], and Dave [Ceryak], for that kind introduction and for inviting me to be with you this year. FDLI is such an important partner for FDA, not only during this meeting, but throughout the year. As you know well, the legal and policy issues associated with the products that FDA regulates are seemingly endless and occur almost daily. Sometimes more than once a day, in my experience. So there’s a lot of work to do together.